40 related articles for article (PubMed ID: 38726026)
1. Predicting human epidermal growth factor receptor 2 status of patients with gastric cancer by computed tomography and clinical features.
Li Y; Dai WG; Lin Q; Wang Z; Xu H; Chen Y; Wang J
Gastroenterol Rep (Oxf); 2024; 12():goae042. PubMed ID: 38726026
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer.
Puhr HC; Reiter TJ; Preusser M; Prager GW; Ilhan-Mutlu A
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980786
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of multivariate models integrating preoperative clinicopathological and radiographic findings to predict HER2 status in gastric cancer.
Xu M; Liu S; Li L; Qiao X; Ji C; Tan L; Zhou Z
Sci Rep; 2022 Aug; 12(1):14177. PubMed ID: 35986169
[TBL] [Abstract][Full Text] [Related]
4. FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group.
Hofheinz RD; Merx K; Haag GM; Springfeld C; Ettrich T; Borchert K; Kretzschmar A; Teschendorf C; Siegler G; Ebert MP; Goekkurt E; Mahlberg R; Homann N; Pink D; Bechstein W; Reichardt P; Flach H; Gaiser T; Battmann A; Oduncu FS; Loose M; Sookthai D; Pauligk C; Göetze TO; Al-Batran SE
J Clin Oncol; 2022 Nov; 40(32):3750-3761. PubMed ID: 35709415
[TBL] [Abstract][Full Text] [Related]
5. The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram.
Wang S; Chen Y; Zhang H; Liang Z; Bu J
Front Oncol; 2021; 11():707686. PubMed ID: 34722254
[TBL] [Abstract][Full Text] [Related]
6. Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group.
Hofheinz RD; Hegewisch-Becker S; Kunzmann V; Thuss-Patience P; Fuchs M; Homann N; Graeven U; Schulte N; Merx K; Pohl M; Held S; Keller R; Tannapfel A; Al-Batran SE
Int J Cancer; 2021 Sep; 149(6):1322-1331. PubMed ID: 34019698
[TBL] [Abstract][Full Text] [Related]
7. Dual-Energy CT-Based Nomogram for Decoding HER2 Status in Patients With Gastric Cancer.
Zhao H; Li W; Huang W; Yang Y; Shen W; Liang P; Gao J
AJR Am J Roentgenol; 2021 Jun; 216(6):1539-1548. PubMed ID: 33852330
[No Abstract] [Full Text] [Related]
8. Current treatment and recent progress in gastric cancer.
Joshi SS; Badgwell BD
CA Cancer J Clin; 2021 May; 71(3):264-279. PubMed ID: 33592120
[TBL] [Abstract][Full Text] [Related]
9. Diameter of Superior Rectal Vein - CT Predictor of KRAS Mutation in Rectal Carcinoma.
Song C; Shen B; Dong Z; Fan Z; Xu L; Li ZP; Li Y; Feng ST
Cancer Manag Res; 2020; 12():10919-10928. PubMed ID: 33154671
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer.
Smyth EC; Nilsson M; Grabsch HI; van Grieken NC; Lordick F
Lancet; 2020 Aug; 396(10251):635-648. PubMed ID: 32861308
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced CT Parameters of Gastric Adenocarcinoma: Can Radiomic Features Be Surrogate Biomarkers for HER2 Over-Expression Status?
Wang N; Wang X; Li W; Ye H; Bai H; Wu J; Chen M
Cancer Manag Res; 2020; 12():1211-1219. PubMed ID: 32110095
[TBL] [Abstract][Full Text] [Related]
12. Venous Invasion in Gastric Cancer.
Ünal E; Karcaaltincaba M
AJR Am J Roentgenol; 2020 Jan; 214(1):W67. PubMed ID: 31860357
[No Abstract] [Full Text] [Related]
13. CT-Detected Extramural Vessel Invasion and Regional Lymph Node Involvement in Stage T4a Gastric Cancer for Predicting Progression-Free Survival.
Cheng J; Feng C; Zhang Y; Hong N; Ye Y; Wang Y
AJR Am J Roentgenol; 2019 May; 212(5):1030-1036. PubMed ID: 30779670
[No Abstract] [Full Text] [Related]
14. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
15. Iodine Concentration in Spectral CT: Assessment of Prognostic Determinants in Patients With Gastric Adenocarcinoma.
Liang P; Ren XC; Gao JB; Chen KS; Xu X
AJR Am J Roentgenol; 2017 Nov; 209(5):1033-1038. PubMed ID: 28871809
[TBL] [Abstract][Full Text] [Related]
16. Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics.
Lee JS; Kim SH; Im SA; Kim MA; Han JK
Korean J Radiol; 2017; 18(5):809-820. PubMed ID: 28860898
[TBL] [Abstract][Full Text] [Related]
17. HER2 testing in gastric cancer: An update.
Abrahao-Machado LF; Scapulatempo-Neto C
World J Gastroenterol; 2016 May; 22(19):4619-25. PubMed ID: 27217694
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
Chen R; Zhou X; Liu J; Huang G
J Nucl Med; 2016 Jul; 57(7):1040-4. PubMed ID: 26966162
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
